TECH Technical Analysis
As of date:8/16/2022
TECH stock price:370.06
TECH 50 DMA:358.40
TECH 200 DMA:409.71
TECH MACD (200-50):51.31
TECH RSI:47.79
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)47.79
Extremely
Oversold

Also see:
TECH Market Cap History
TECH Shares Outstanding History
TECH YTD Return

Try ChartSweeps today
Quotes delayed 20 minutes

Email EnvelopeFree TECH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

FFIC Makes Bullish Cross Above Critical Moving Average
12 hours, 12 minutes ago


Huntington Bancshares (HBAN) Shares Cross Above 200 DMA
12 hours, 13 minutes ago


CHKP Makes Bullish Cross Above Critical Moving Average
12 hours, 13 minutes ago


VLY Makes Bullish Cross Above Critical Moving Average
12 hours, 13 minutes ago


CSB Shares Cross Above 200 DMA
12 hours, 13 minutes ago


Light & Wonder Breaks Above 200-Day Moving Average - Bullish for LNW
16 hours, 11 minutes ago


Vivint Smart Home Breaks Above 200-Day Moving Average - Bullish for VVNT
16 hours, 21 minutes ago


Alpine Income Property Trust (PINE) Shares Cross Above 200 DMA
16 hours, 21 minutes ago


Bullish Two Hundred Day Moving Average Cross - BERY
16 hours, 30 minutes ago


FLT Crosses Above Key Moving Average Level
16 hours, 30 minutes ago


TE Connectivity Breaks Above 200-Day Moving Average - Bullish for TEL
16 hours, 34 minutes ago


AX Makes Bullish Cross Above Critical Moving Average
16 hours, 34 minutes ago


Gray Television Breaks Above 200-Day Moving Average - Bullish for GTN
16 hours, 34 minutes ago


AREN Crosses Above Key Moving Average Level
16 hours, 34 minutes ago


AWI Crosses Above Key Moving Average Level
16 hours, 34 minutes ago


More Technical Analysis News

TECH Technical AnalysisTECH RSI
Bio-Techne develops, manufactures and sells life science reagents, instruments and services for the research, diagnostics and bioprocessing markets. Co.'s segments include: Protein Sciences, which develops and manufactures biological reagents used in life science research, diagnostics and cell and gene therapy; and Diagnostics and Genomics, which develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications.

When researching a stock like Bio-Techne, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from TECH Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for TECH stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
TECH DMATECH MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bio-Techne (TECH) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

TFX Technical Analysis
TMO Technical Analysis
UHS Technical Analysis
VRTX Technical Analysis
VTRS Technical Analysis
WAT Technical Analysis
XRAY Technical Analysis
ZBH Technical Analysis
ZTS Technical Analysis
A Technical Analysis
More Healthcare companies »

 

TECH Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2022, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.